Using molecular docking, we aimed to examine whether each moiety of the engineered fusion proteins could bind to its receptor
Metsera Competes in Crowded Next-Gen Weight Loss Space Metseras results land amid a flurry of data readouts from next-gen candidates under development by small biotech peers and Big Pharma rivals
How Weight Loss Changes Your Face: What GLP-1 Patients Need to Know GLP-1 medications like Tirzepatide and Semaglutide have transformed weight loss outcomes for millions of patients, but rapid fat loss doesnt discriminate between body regions
Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes
Persistent or severe sweating , particularly if it disrupts daily activities or sleep, should be discussed with a GP or diabetes specialist nurse